Scott Parker, MD
Infectious Disease · Huntsville, ALNPI 1992716120
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 520 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,293, 2.9 times the $804 reported in 2019.
Across 520 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Insmed, Inc.$1K
- Melinta Therapeutics, LLC$982
- AbbVie$806
- Merck$768
- Astellas Pharma US Inc$748
- plus $4K from 32 others
What the payments were for
- Food & beverage$9,85193%
- Education$7167%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,567 in reported general payments places this provider in the 75th percentile of 104 infectious disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DalvanceDalbavancin Hcl | 193 | $771,703 |
| ArikayceAmikacin Liposomal/Neb.Accessr | 16 | $249,330 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 36 | $194,181 |
| DovatoDolutegravir Sodium/Lamivudine | 40 | $139,134 |
| JulucaDolutegravir/Rilpivirine | 26 | $104,536 |
| Daptomycin | 64 | $52,879 |
| ErtapenemErtapenem Sodium | 99 | $38,590 |
| TivicayDolutegravir Sodium | 15 | $33,119 |
| DescovyEmtricitabine/Tenofov Alafenam | 12 | $30,698 |
| PrezcobixDarunavir/Cobicistat | 13 | $30,064 |
| SantylCollagenase Clostridium Hist. | 29 | $22,802 |
| Darunavir | 12 | $19,012 |
| OzempicSemaglutide | 15 | $10,856 |
| Cefepime Hcl | 72 | $10,033 |
| Cefpodoxime Proxetil | 65 | $9,218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieDalvance | $806 | $771,703193 claims |
| Viiv Healthcare CompanyDovato, Juluca, Tivicay | $1,945 | $276,79081 claims |
| Insmed, Inc.Arikayce | $1,246 | $249,33016 claims |
| GileadDescovy | $663 | $30,69812 claims |
| Johnson & JohnsonPrezcobix | $188 | $30,06413 claims |
| Smith+NephewSantyl | $373 | $22,80229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 104 infectious disease providers in Alabama.
Other infectious disease in Huntsville
- Ali HassounHuntsville$262K
- Hafsa SiddiquiHuntsville$5K
- Andres Gutierrez OrdonezHuntsville$2K
- Richard SperaHuntsville$2K
- Jordan Micah PolisticoHuntsville$1K
- Ingrid RoigHuntsville$646
- Tommy Parraga AcostaHuntsville$613
- John BaddleyBirmingham$113K
- Christina MuznyBirmingham$111K
- Carlos Reyes-SacinMontgomery$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.